A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Eli Lilly & CO stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 428,864 shares of LLY stock, worth $341 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
428,864
Previous 470,489 8.85%
Holding current value
$341 Million
Previous $426 Million 10.8%
% of portfolio
1.21%
Previous 1.46%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $32.1 Million - $40 Million
-41,625 Reduced 8.85%
428,864 $380 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $155 Million - $194 Million
-213,297 Reduced 31.19%
470,489 $426 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $3.6 Million - $4.81 Million
-6,077 Reduced 0.88%
683,786 $532 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $16 Million - $18.8 Million
30,370 Added 4.61%
689,863 $402 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $68.2 Million - $94 Million
-156,780 Reduced 19.21%
659,493 $354 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $9.97 Million - $13.3 Million
28,426 Added 3.61%
816,273 $383 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $3.38 Million - $3.97 Million
10,877 Added 1.4%
787,847 $271 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $3.17 Million - $3.7 Million
-9,871 Reduced 1.25%
776,970 $284 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $909,600 - $1.04 Million
-3,068 Reduced 0.39%
786,841 $254 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $38 Million - $44.6 Million
-136,417 Reduced 14.73%
789,909 $256 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $15.1 Million - $18.8 Million
-64,469 Reduced 6.51%
926,326 $265 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $3 Million - $3.72 Million
-13,334 Reduced 1.33%
990,795 $274 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $3.26 Million - $4.01 Million
14,707 Added 1.49%
1,004,129 $232 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $33.6 Million - $43.5 Million
-186,299 Reduced 15.85%
989,422 $227 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $3.85 Million - $4.98 Million
23,403 Added 2.03%
1,175,721 $220 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $27.1 Million - $35.8 Million
-207,505 Reduced 15.26%
1,152,318 $195 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $4.73 Million - $5.48 Million
32,382 Added 2.44%
1,359,823 $201 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $674,869 - $812,198
-4,947 Reduced 0.37%
1,327,441 $218 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $53.6 Million - $66.4 Million
-450,536 Reduced 25.27%
1,332,388 $185 Million
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $214,267 - $265,389
2,004 Added 0.11%
1,782,924 $234 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $20.2 Million - $22 Million
189,524 Added 11.91%
1,780,920 $199 Million
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $173 Million - $202 Million
1,563,537 Added 5612.32%
1,591,396 $176 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $31.4 Million - $37 Million
-282,200 Reduced 91.01%
27,859 $3.62 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $6.71 Million - $7.52 Million
-63,400 Reduced 16.98%
310,059 $35.9 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $4.3 Million - $5.38 Million
-50,100 Reduced 11.83%
373,459 $40.1 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $68.6 Million - $78.7 Million
-905,790 Reduced 68.14%
423,559 $36.1 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $25.9 Million - $30.5 Million
348,500 Added 35.53%
1,329,349 $103 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $14.7 Million - $15.7 Million
178,800 Added 22.29%
980,849 $82.8 Million
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $5.03 Million - $5.58 Million
-65,224 Reduced 7.52%
802,049 $68.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
867,273
867,273 $71.4 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.